References
Metawi SA, Abbas D, Kamal MM, Ibrahim MK (2011) Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol 30(9):1201–1207
Li X, Yuan FL, Lu WG, Zhao YQ, Li CW, Li JP, Xu RS (2010) The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis. Biochem Biophys Res Commun 397(2):131–135
Ryu S, Lee JH, Kim SI (2006) IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes. Clin Rheumatol 25(1):16–20
Paradowska A, Masliniski W, Grzybowska-Kowalczyk A, Lacki J (2007) The function of interleukin 17 in the pathogenesis of rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) 55(5):329–334
van den Berg WB, Miossec P (2009) IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol 5(10):549–553
Moran EM, Mullan R, McCormick J, Connolly M, Sullivan O, Fitzgerald O, Bresnihan B, Veale DJ, Fearon U (2009) Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies. Arthritis Res Ther 11(4):R113
Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P (1999) Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42(5):963–970
Lubberts E (2010) Th17 cytokines and arthritis. Semin Immunopathol 32(1):43–53
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yuan, FL., Li, X., Li, CW. et al. Expanded role for interleukin-17 in rheumatoid arthritis. Clin Rheumatol 31, 189–190 (2012). https://doi.org/10.1007/s10067-011-1869-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1869-0